-
Pluristem Therapeutics Announces Receipt Of 2 Key Cell Therapy Patents In Japan; Shares Tick Higher
Wednesday, April 13, 2016 - 8:51am | 305Read More...Shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI), a bio-therapeutics company focusing on the treatment of multiple ischemic and inflammatory conditions, were trading higher by more than 7 percent early Wednesday morning after the company announced it was granted two key cell therapy patents....
